Green Plains Renewable Energy IncGPRE
± MixedCapitalrelevance
Revenue miss but EPS beat; management discusses operations and buybacks under review.
Impact on stocks 1
Synthetic Biology (non-pharma)
Green Plains Renewable Energy IncGreen Plains reported second-quarter revenue of $446.2 million, missing analyst estimates of $560 million and marking a 19.3% year-on-year decline, while adjusted EPS of $0.83 beat estimates of $0.64. Management attributed the quarter to operational improvements, successful spring maintenance, and expanded contributions from its carbon platform. During the earnings call, analysts focused on spring maintenance details, ethanol export demand sustainability, corn oil yield improvements, base ethanol business outlook, and utilization trends. CEO Chris Osowski reiterated a goal of 95% annualized utilization, and CFO Ann Reis said share repurchases remain under review with no announcements made.
Green Plains Renewable Energy IncRevenue miss but EPS beat; management discusses operations and buybacks under review.